Concepedia
Statistics
Publications
10
Citations
474
H-Index
Active since
2012
Affiliations
Leiden University Medical Center(Current)
Leiden University
Idera Pharmaceuticals (United States)
Amsterdam UMC Location Vrije Universiteit Amsterdam
Odense University Hospital
S. Welten is an author at Leiden University Medical Center specializing in life sciences, microrna biology, and molecular biology.
Publications per year
2012–2018
Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 Increases Neovascularization and Blood Flow Recovery After Ischemia
S. Welten, A.J.N.M. Bastiaansen, Rob C. M. de Jong et al. · Circulation Research · 2014 · 142 citations
Medicine, Biomedical Sciences, Molecular Medicine +16
Lysine Acetyltransferase PCAF Is a Key Regulator of Arteriogenesis
A.J.N.M. Bastiaansen, M.M. Ewing, Hetty C. de Boer et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 62 citations · Full text
Life Sciences, Molecular Biology, Pharmacology +16
The 14q32 MicroRNA-487b Targets the Antiapoptotic Insulin Receptor Substrate 1 in Hypertension-Induced Remodeling of the Aorta
A. Yaël Nossent, Tilde Eskildsen, Lene B. Andersen et al. · Annals of Surgery · 2013 · 44 citations
Life Sciences, Cardiology, Molecular Biology +17
Identification of novel Sp1 targets involved in proliferation and cancer by functional genomics
Carlota Oleaga, S. Welten, A Belloc et al. · Biochemical Pharmacology · 2012 · 43 citations
Life Sciences, Molecular Biology, Oncology +11
Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability
Anouk Wezel, S. Welten, Wida Razawy et al. · Annals of Surgery · 2015 · 43 citations
1–5 of 10